02Apr 2021
Imiquimod accelerated antitumor response by targeting lysosome adaptation in skin cancer cells

Imiquimod accelerated antitumor response by targeting lysosome adaptation in skin cancer cells

Lysosomal adaptation is a cellular physiological process in which the number and function of lysosomes are regulated at the transcriptional and posttranscriptional levels in response to extracellular/intracellular cues or lysosomal damage. Imiquimod, a synthetic Toll-like receptor 7 ligand with hydrophobic and weak basic properties, exhibits both antitumor and antiviral activity against various skin malignancies as a clinical treatment...

  • #dermatology

Like

Save

Share